April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, has  announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation (BDD) for atrioventricular interval modulation (AVIM) therapy.

April 28, 2025 — The Society of Thoracic Surgeons (STS) has launched its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without concomitant aortic valve replacement (AVR). This first-of-its-kind tool represents a major step forward in risk stratification and personalized surgical planning for complex aortic operations.

April 25, 2025 – Medtronic plc, a global leader in healthcare technology, recently received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for placement within the right ventricle. The lead, built on the highly reliable SelectSecure Model 3830 pacing lead and delivered via catheter, builds on the Medtronic portfolio of lead solutions designed for precise delivery and placement.

April 24, 2025 — HeartBeam, Inc. recently announced a strategic collaboration with AccurKardia to enhance the accessibility of cardiac monitoring solutions and will focus on making AccurKardia’s FDA-cleared ECG analysis software, AccurECG, available on HeartBeam’s devices.* 

April 27, 2025 – The Heart Rhythm Society (HRS) has announced the findings of new studies demonstrating the safety and efficacy of emerging pulsed field ablation (PFA) systems during Heart Rhythm 2025 in San Diego, California.  

April 25, 2025 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI 2025 Scientific Sessions, will kick off May 1, 2025, at the Walter E. Washington Convention Center in Washington, D.C. Nearly 2,000 scientists, researchers, innovators, and clinicians are expected to attend to discuss advances in the field of interventional cardiology and endovascular medicine. 

April 25, 2025 – Findings from two late-breaking clinical trials demonstrate the safety and efficacy of left bundle branch area pacing (LBBAP), adding to the growing body of evidence supporting new pacing methods. Researchers presented these findings as late-breaking clinical science during Heart Rhythm 2025.

April 24, 2025 – The Heart Rhythm Society (HRS) has unveiled new research that underscores the critical role of artificial intelligence (AI) in improving procedural safety in cardiac electrophysiology (EP), demonstrating how intelligent, real-time decision support can help mitigate risks and improve clinical confidence in complex interventions. Researchers presented these findings at Heart Rhythm 2025 in San Diego, California. 

April 23, 2025 – The Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.

April 24, 2025 – The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) have released a scientific statement on new guiding principles for Same-Day Discharge (SDD) for patients undergoing intracardiac catheter ablation procedures. This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now